Pregnancy after myocardial revascularization

November 27, 2020

Clinical case simulator “Pregnancy after myocardial revascularization”. A young woman who has had multiple recurrent myocardial infarctions and coronary artery stenting learns about her pregnancy and decides to keep the pregnancy. What are the features of managing such a group of patients? Is the correction of drug therapy necessary? What can be the tactics of patient management, taking into account the planned delivery?

  • You will communicate with the patient in dialogue simulators;
  • Will conduct an objective examination of the patient;
  • Will reexamine patient’s СD’s with imaging studies;
  • Will carry out the necessary additional examinations;
  • You will take part in the obstetric and cardiological consultation;
  • Will remember structure and function of platelets;
  • Will remember classification of antiplatelet drugs;
  • Will analyze types of hypertension in pregnant women;
  • Will get acquainted with the classification of drugs by hazard class in pregnant women;
  • Will get acquainted with the general algorithm of drug therapy for patients after myocardial revascularization in the context of planning for non-cardiac surgery;
  • Will сhoose the most optimal drug therapy strategy for the patient, taking into account the pregnancy and the upcoming delivery.

Clinical case simulator “Pregnancy after myocardial revascularization”:

  • More than 9 locations;
  • 4 interactive simulators;
  • Consilium;
  • Gamification;
  • Branching-scenario;
  • Visualization of diagnostic tests;
  • Over 90 practice questions with explanations and comments;
  • Analysis of clinical guidelines based on a particular clinical situation;
  • Number of competencies – 18.

Total duration: 2–2.5 hours.

Devices for training in the clinical case simulator:

  • Tablets
  • Laptops
  • Computers

One-time purchase of one simulator

Sign up

Associated case simulator: “Choosing the duration of DAPT administration after coronary stenting in a young woman”

Share:

Responses

Your email address will not be published.